Apoptosis: Life through planned cellular death regulating mechanisms, control systems, and relations with thyroid diseases

被引:20
作者
Lumachi, F [1 ]
Basso, S [1 ]
机构
[1] Univ Padua, Sch Med, Dept Surg & Gastroenterol Sci, Endocrine Surg Unit, I-35128 Padua, Italy
关键词
D O I
10.1089/105072502753451931
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Apoptosis is an active biologic process that represents a form of programmed cellular suicide, activated either by genetic factors or by cellular lesions caused by various extracellular traumatic agents. The alterations of its functional mechanisms control cellular homeostasis are involved in the genesis of many illnesses. There are different control systems that can both stimulate and inhibit apoptosis, such as the p53 and Bcl-2 proteins. Different injuries may cause a rapid increase in the levels of p53 and the activation of the complex mechanism which leads either to damage repair or cellular apoptosis. The concept of tumor growth as a dynamic balance between cellular development and death is well applicable to differentiated thyroid carcinomas, which are generally not highly invasive and present excellent prognosis. On the contrary, in aggressive anaplastic thyroid carcinoma there is an increase in p53, whereas in normal thyroid cells there is a high expression of Bcl-2, so as to interfere with apoptosis when physiologic hormone levels are normal. However, only some of the biomolecular mechanisms behind the genesis of thyroid tumors have been explained, and the role of apoptosis in thyroid diseases has not been well defined. T his review provides information about relationship between apoptosis and thyroid diseases.
引用
收藏
页码:27 / 34
页数:8
相关论文
共 89 条
  • [41] Leach A P, 1998, Clin Lab Sci, V11, P346
  • [42] p53, the cellular gatekeeper for growth and division
    Levine, AJ
    [J]. CELL, 1997, 88 (03) : 323 - 331
  • [43] p53 protein at the hub of cellular DNA damage response pathways through sequence-specific and non-sequence-specific DNA binding
    Liu, YG
    Kulesz-Martin, M
    [J]. CARCINOGENESIS, 2001, 22 (06) : 851 - 860
  • [44] P53-DEPENDENT APOPTOSIS MODULATES THE CYTOTOXICITY OF ANTICANCER AGENTS
    LOWE, SW
    RULEY, HE
    JACKS, T
    HOUSMAN, DE
    [J]. CELL, 1993, 74 (06) : 957 - 967
  • [45] Lu QL, 1996, HUM PATHOL, V27, P102, DOI 10.1016/S0046-8177(96)90362-7
  • [46] A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation
    Lutzker, SG
    Levine, AJ
    [J]. NATURE MEDICINE, 1996, 2 (07) : 804 - 810
  • [47] GERM LINE P53 MUTATIONS IN A FAMILIAL SYNDROME OF BREAST-CANCER, SARCOMAS, AND OTHER NEOPLASMS
    MALKIN, D
    LI, FP
    STRONG, LC
    FRAUMENI, JF
    NELSON, CE
    KIM, DH
    KASSEL, J
    GRYKA, MA
    BISCHOFF, FZ
    TAINSKY, MA
    FRIEND, SH
    [J]. SCIENCE, 1990, 250 (4985) : 1233 - 1238
  • [48] Apoptosis - Caspases find a new place to hide
    Mehmet, H
    [J]. NATURE, 2000, 403 (6765) : 29 - 30
  • [49] Effects of thyroid hormones on apoptotic cell death of human lymphocytes
    Mihara, S
    Suzuki, N
    Wakisaka, S
    Suzuki, S
    Sekita, N
    Yamamoto, S
    Saito, N
    Hoshino, T
    Sakane, T
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (04) : 1378 - 1385
  • [50] Mitsiades N, 2000, CANCER RES, V60, P4122